Concepedia

A phase I dose escalation study of epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitor CP-358,774 in patients (pts) with advanced solid tumors

Daniel D. Karp, Karen J. Ferrante, Thomas G. Tensfeldt, Robert L. Thurer, Joseph LoCicero, Mark S. Huberman, Francesca Wirth, Richard Hellman, Patrick Poulin, Sandra Silberman,

Lung Cancer · 2000 · 58 citations · 0 references

DOI

Concepts